Src
Src(Src激酶)
Src (proto-oncogene tyrosine-protein kinase) is a non-receptor protein tyrosine kinase family including 9 members and promotes survival, angiogenesis, proliferation and invasion pathways.
Src 相关产品(101)
- GC341191-Naphthyl PP1 hydrochloride (1-NA-PP 1 hydrochloride)CAS: 956025-47-1纯度: >99.50%
1-Naphthyl PP1 hydrochloride 是 src 家族激酶 v-Src 的选择性抑制剂
- GC36430Lck inhibitor 2CAS: 944795-06-6纯度: >98.00%
Lck inhibitor 2是多靶点酪氨酸激酶抑制剂,对Lck,Btk,Lyn,Btk和Txk的IC50分别为13nM,9nM,3nM,26nM和2nM。
- GC37620Secretin, canineCAS: 110786-77-1
Secretin, canine 是一种内分泌激素,刺激分泌富含碳酸氢盐的胰液。Secretin, canine 可通过Src激酶依赖途径调节胃单层细胞的主要细胞功能和旁细胞通透性。
- GC37772TG 100572 HydrochlorideCAS: 867331-64-4纯度: >99.50%
TG 100572 Hydrochloride 是多靶点激酶抑制剂,抑制受体酪氨酸激酶 (receptor tyrosine kinases) 和Src激酶 (Src kinases); 对VEGFR1,VEGFR2,FGFR1,FGFR2,PDGFRβ,Fgr,Fyn,Hck,Lck,Lyn,Src,Yes 的 IC50 值分别为2,7,2,16,13,5,0.5,6,0.1,0.4,1,0.2 nM。
- GC37773TG 100801 HydrochlorideCAS: 1018069-81-2
TG 100801 Hydrochloride 是TG 100572的前药,通过去酯化产生TG 100572,开发用来治疗年龄相关的黄斑变性。TG 100572是多靶点激酶抑制剂,抑制受体酪氨酸激酶 (receptor tyrosine kinases) 和Src激酶 (Src kinases); 对VEGFR1,VEGFR2,FGFR1,FGFR2,PDGFRβ,Fgr,Fyn,Hck,Lck,Lyn,Src,Yes 的 IC50 值分别为2,7,2,16,13,5,0.5,6,0.1,0.4,1,0.2。
- GC38006β-HydroxyisovalerylshikoninCAS: 7415-78-3纯度: >99.50%
Beta-hydroxyisovalerylshikonin 是一种从Lithospermium radix 中分离出的天然产物,是一种有效的 PTK 抑制剂, 对 EGFR 和 v-Src 受体作用的 IC50 分别为 0.7 μM 和 1 μM。Beta-hydroxyisovalerylshikonin 对多种肿瘤细胞系均有抑制作用,能高效诱导 NCI-H522 和 DMS114 细胞的死亡。
- GC40080Bosutinib-d8CAS: 2733145-45-2纯度: >99.00%
An internal standard for the quantification of bosutinib
- GC426167-oxo StaurosporineCAS: 125035-83-8纯度: >98.00%
An antibiotic with diverse biological activities
- GC45828Ponatinib-d8CAS: 1562993-37-6纯度: >99.00%
An internal standard for the quantification of ponatinib
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC34109 | Tirbanibulin Mesylate (KX2-391 (Mesylate)) | 1080645-95-9 | >99.50% | |
A Src kinase inhibitor | ||||
| GC34110 | WEHI-345 analog | 1354825-62-9 | >99.00% | |
WEHI-345(analog)是一种Src抑制剂。 | ||||
| GC34119 | 1-Naphthyl PP1 hydrochloride (1-NA-PP 1 hydrochloride) | 956025-47-1 | >99.50% | |
1-Naphthyl PP1 hydrochloride 是 src 家族激酶 v-Src 的选择性抑制剂 | ||||
| GC35209 | A 419259 | 364042-47-7 | - | |
An inhibitor of Src family kinases | ||||
| GC35213 | A-770041 | 869748-10-7 | >99.00% | |
A LCK kinase inhibitor | ||||
| GC35812 | Dasatinib hydrochloride | 854001-07-3 | >98.50% / >99.00% | |
An inhibitor of Abl and Src | ||||
| GC36430 | Lck inhibitor 2 | 944795-06-6 | >98.00% | |
Lck inhibitor 2是多靶点酪氨酸激酶抑制剂,对Lck,Btk,Lyn,Btk和Txk的IC50分别为13nM,9nM,3nM,26nM和2nM。 | ||||
| GC36546 | Masitinib mesylate | 1048007-93-7 | >99.50% | |
An inhibitor of c-Kit | ||||
| GC37620 | Secretin, canine | 110786-77-1 | - | |
Secretin, canine 是一种内分泌激素,刺激分泌富含碳酸氢盐的胰液。Secretin, canine 可通过Src激酶依赖途径调节胃单层细胞的主要细胞功能和旁细胞通透性。 | ||||
| GC37771 | TG 100572 | 867334-05-2 | - | |
TG 100572是多靶点激酶抑制剂,抑制受体酪氨酸激酶 (receptor tyrosine kinases) 和Src激酶 (Src kinases); 对VEGFR1,VEGFR2,FGFR1,FGFR2,PDGFRβ,Fgr,Fyn,Hck,Lck,Lyn,Src,Yes 的 IC50 值分别为2,7,2,16,13,5,0.5,6,0.1,0.4,1,0.2 nM。 | ||||
| GC37772 | TG 100572 Hydrochloride | 867331-64-4 | >99.50% | |
TG 100572 Hydrochloride 是多靶点激酶抑制剂,抑制受体酪氨酸激酶 (receptor tyrosine kinases) 和Src激酶 (Src kinases); 对VEGFR1,VEGFR2,FGFR1,FGFR2,PDGFRβ,Fgr,Fyn,Hck,Lck,Lyn,Src,Yes 的 IC50 值分别为2,7,2,16,13,5,0.5,6,0.1,0.4,1,0.2 nM。 | ||||
| GC37773 | TG 100801 Hydrochloride | 1018069-81-2 | - | |
TG 100801 Hydrochloride 是TG 100572的前药,通过去酯化产生TG 100572,开发用来治疗年龄相关的黄斑变性。TG 100572是多靶点激酶抑制剂,抑制受体酪氨酸激酶 (receptor tyrosine kinases) 和Src激酶 (Src kinases); 对VEGFR1,VEGFR2,FGFR1,FGFR2,PDGFRβ,Fgr,Fyn,Hck,Lck,Lyn,Src,Yes 的 IC50 值分别为2,7,2,16,13,5,0.5,6,0.1,0.4,1,0.2。 | ||||
| GC38006 | β-Hydroxyisovalerylshikonin | 7415-78-3 | >99.50% | |
Beta-hydroxyisovalerylshikonin 是一种从Lithospermium radix 中分离出的天然产物,是一种有效的 PTK 抑制剂, 对 EGFR 和 v-Src 受体作用的 IC50 分别为 0.7 μM 和 1 μM。Beta-hydroxyisovalerylshikonin 对多种肿瘤细胞系均有抑制作用,能高效诱导 NCI-H522 和 DMS114 细胞的死亡。 | ||||
| GC38864 | TL02-59 | 1315330-17-6 | >99.50% | |
TL02-59 is an orally active, selective Src-family kinase Fgr inhibitor with an IC50 of 0.03 nM. | ||||
| GC40054 | CCT241161 | 1163719-91-2 | >98.00% | |
A multi-kinase inhibitor | ||||
| GC40080 | Bosutinib-d8 | 2733145-45-2 | >99.00% | |
An internal standard for the quantification of bosutinib | ||||
| GC42616 | 7-oxo Staurosporine | 125035-83-8 | >98.00% | |
An antibiotic with diverse biological activities | ||||
| GC44583 | PD 089828 | 179343-17-0 | >98.00% | |
An inhibitor of EGFR, PDGFβ, FGF, and c-Src | ||||
| GC44977 | Syk Inhibitor | 622387-85-3 | >95.00% | |
Potently blocks spleen tyrosine kinase activity | ||||
| GC45687 | Dasatinib N-oxide | 910297-52-8 | >95.00% | |
A major metabolite of dasatinib | ||||
| GC45828 | Ponatinib-d8 | 1562993-37-6 | >99.00% | |
An internal standard for the quantification of ponatinib | ||||
| GC46924 | BIBF 1120-13C-d3 | - | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC47771 | NG 25 (hydrochloride hydrate) | - | >98.00% | |
An inhibitor of MAP4K2 and TAK1 | ||||
| GC48992 | CGP 77675 (hydrate) | - | >98.00% | |
An inhibitor of Src family kinases | ||||
